Mullins, N
Hodgson, K
Tansey, K E
Perroud, N
Maier, W
Mors, O
Rietschel, M
Hauser, J
Henigsberg, N http://orcid.org/0000-0002-5303-1834
Souery, D
Aitchison, K http://orcid.org/0000-0002-1107-3024
Farmer, A
McGuffin, P
Breen, G http://orcid.org/0000-0003-2053-1792
Uher, R
Lewis, C M
Article History
Received: 2 May 2014
Revised: 29 July 2014
Accepted: 4 September 2014
First Online: 28 October 2014
Competing interests
: AF and PM have received consultancy fees and honoraria for participating in expert panels for pharmaceutical companies, including GlaxoSmithKline. CML has received consultancy honoraria from Eli Lilly. The remaining authors declare no conflict of interest.